ADBIOTECH completes 7.27 million share third-party allotment raising 13.3 billion KRW, causing over 36% dilution for existing shareholders
ADBIOTECH completed its third-party allotment capital increase on June 4 2026 as resolved by the board on October 27 2025, issuing 7,270,669 new shares for approximately 13.3 billion KRW.
The new shares are scheduled to be listed on June 23 2026, resulting in a dilution ratio of 36.95% relative to the existing 19,679,630 shares outstanding, severely impacting existing shareholder value.
The issuance price of about 1,824 KRW per share represents a 25.8% premium to the current price of 2,460 KRW but the absence of stated use of proceeds raises significant investment risk.
The counterparty in this allotment is undisclosed indicating low governance transparency and investors should prepare for potential short-term price declines.
[AI Summary]ADBIOTECH's massive 7.27 million share third-party allotment dilutes existing shareholder value by over 36% representing a major negative event. The undisclosed use of funds and opaque counterparty severely undermine credibility and will likely pressure the stock price downward.